Targeted alpha therapy

QScint offers tools to support your cancer treatment research

Study the fate of therapeutic radionuclides

Establishing the fate of parent and child isotopes in tissue during targeted alpha therapy is an important step in bringing targeted alpha therapy products to market. The iQID family of imagers allows you to see where these isotopes end up in tissue.

View the iQID line or contact us for assistance in selecting the right iQID for your application.